To hear about similar clinical trials, please enter your email below
Trial Title:
Clinical Value of Prick Therapy Combined With Wheat Grain Moxibustion in the Treatment of Spleen Deficiency and Dampness Obstructed Cancer
NCT ID:
NCT06074718
Condition:
Pricking Therapy on the Back Shu Points
Wheat Grain Moxibustion on the Back Shu Points
Conditions: Keywords:
spleen deficiency and dampness obstructed
cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
pricking therapy and wheat grain moxibustion
Description:
pricking therapy and wheat grain moxibustion on the back shu points or positive reaction
points
Arm group label:
chemotherapy
Arm group label:
pricking therapy and wheat grain moxibustion combined with chemotherapy
Summary:
This study aims to investigate the clinical efficacy and associated immune and
inflammatory mechanisms in patients with malignant tumors of spleen deficiency and
dampness resistance type, by applying pricking therapy and wheat grain moxibustion on the
back shu points or positive reaction points.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Clinical diagnosis of Western medicine and traditional Chinese medicine for
malignant tumors;
- Clinical diagnosis of spleen deficiency dampness obstruction in traditional Chinese
medicine;
- Good compliance and signed informed consent form.
Exclusion Criteria:
- Patients who cannot lie prone for a long time;
- Pregnant women;
- Lactating women
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Qingtao Ni
Address:
City:
Taizhou
Zip:
225300
Country:
China
Status:
Recruiting
Contact:
Last name:
Qingtao Ni
Phone:
18852656280
Email:
nqt1990@126.com
Start date:
January 2, 2024
Completion date:
September 2024
Lead sponsor:
Agency:
Jiangsu Taizhou People's Hospital
Agency class:
Other
Source:
Jiangsu Taizhou People's Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06074718
